-+ 0.00%
-+ 0.00%
-+ 0.00%

Fosun Co-CEO Outlines Global Drug Expansion Strategy at Shanghai Sustainability Conference

PUBT·10/21/2026 08:45:58
Listen to the news
Fosun Co-CEO Outlines Global Drug Expansion Strategy at Shanghai Sustainability Conference
  • Fosun International co-CEO Chen Qiyu outlined global drug expansion strategy at Sustainability Global Leaders Conference in Shanghai on October 20, 2026.
  • Chen emphasized affordability, reliable quality and greater development efficiency as competitive advantages for Chinese drugmakers expanding globally.
  • Fosun Pharma’s first-half 2026 innovative drug R&D investment rose 48.38% to RMB 2.65 billion.
  • Innovative drug revenue increased 13.84% to RMB 4.91 billion, accounting for 33.35% of pharmaceutical business revenue.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fosun International Limited published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610210445PR_NEWS_USPR_____HK77508) on October 21, 2026, and is solely responsible for the information contained therein.